Sandrine Ferrand

445 citations
10 papers · 248 indexed · h-index 8
Topics
Neuroblastoma Research and Treatments (4 papers)Cancer therapeutics and mechanisms (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)

In The Last Decade

Sandrine Ferrand

10 papers receiving 240 citations

Peers

Sandrine Ferrand
Comparison fields: 5 of 61
  • Molecular Biology 163
  • Neurology 84
  • Cancer Research 41
  • Oncology 39
  • Epidemiology 25
Replace Robert Gustafsson with:
Robert Gustafsson Sweden
Tatjana Starzetz Germany
Iris K. L. Tan Australia
Merav D. Shmueli Israel
Biqing Zhu China
Derek J. Hoelz United States
Jonas P. Becker Germany
Tania Tahtouh France
Ramzi H. Abbassi Australia
C Reilly United States
Sandrine Ferrand relative to Robert Gustafsson Sweden Robert Gustafsson's profile →
Citations per field
00.5×4.2×
Robert Gustafsson · 1×
Citations per year

Countries citing papers authored by Sandrine Ferrand

Since Specialization
Citations

This map shows the geographic impact of Sandrine Ferrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Ferrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Ferrand more than expected).

Fields of papers citing papers by Sandrine Ferrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Ferrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Ferrand. The network helps show where Sandrine Ferrand may publish in the future.

Co-authorship network of co-authors of Sandrine Ferrand

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Ferrand. A scholar is included among the top collaborators of Sandrine Ferrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Ferrand. Sandrine Ferrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 4
2 15
3 28
4 44
5 9
6 32
7 2
8 85
9 10
10 19

About Sandrine Ferrand

Sandrine Ferrand is a scholar working on Neurology, Biophysics and Cancer Research, having authored 10 papers that have together received 248 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (4 papers), Cancer therapeutics and mechanisms (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Neurology (84 citations), Cancer Research (41 citations) and Molecular Biology (163 citations). Sandrine Ferrand has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include J. Fraser Glickman, Isabelle Janoueix‐Lerosey, Gudrun Schleiermacher, Valérie Combaret, Gaëlle Pierron, Olivier Delattre, Emmanuel Barillot, Stéphanie Jouannet, Caroline Louis‐Brennetot and Romain Daveau. Their work appears in journals such as PLoS ONE, Cancer Research and Journal of Alzheimer s Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026